In 1880, Phillip S. Wales, Surgeon General of the Navy, reported that acute respiratory diseases, particularly epidemic catarrh (influenza), bronchitis, and pneumonia were the most common illnesses affecting the sailor (1). He noted, however, that rates for the U.S. Navy were lower than those observed in seamen of foreign naval services. His records reveal respiratory disease hospitalization rates of 14.8 per 1000 fleet personnel per year, with an overall annual incidence of 126 respiratory illnesses per 1000 men. By way of comparison, recent respiratory hospitalizations for active duty Navy and Marine Corps personnel approximate 20-23 per 1000 annually with a shipboard respiratory illness incidence of 1600-1800 per 1000 per year (2) (3) (4) . The apparent differences are probably more closely related to better reporting and classification of disease than they are to actual changes in disease frequency. A fairer comparison may be observed by examining the mortality and disability rates of today's sailor and his predecessor of the 1880s. In the days of "iron ships and iron men" respiratory illness was responsible for a mortality of 77 per 100,000 per year with 88 per 100,000 annual disability separations. The most recent figures for the Navy and Marine Corps indicate a respiratory mortality of 1.5-3.0 per 100,000, and a disability discharge rate of 13/ 100,000 annually (2) (3) (4) .
Of the epidemic respiratory diseases, none has had a greater total population impact than that of influenza. Early texts suggest that the disease was first seen in the United States about 1510, and that large epidemics occurred in Europe in 1782 and 1850 (5). Table 1 lists Navy and Marine Corps admission and mortality rates for influenza during several selected epidemic periods. At the close of World War I, the case mortality rate ranged around 3%. The decreased morbidity and mortality associated with this illness may be related to antigenic shifts, the recent availability of antibiotics and the use of antigen specific vaccines.
Much of our information on other respiratory pathogens affecting the Navy and Marine Corps comes from intensive investigations of illness in recruit populations. (9) . Research during the 1950s and 1960s uncovered adenoviruses and Mycoplasma pneumoniae as being of etiologic significance in recruit respiratory illness (10, 11) . Rhinoviruses were also identified within the latter time interval, and although they occur in up to 20% of incoming recruits, they apparently cause less serious disease and are considered of secondary importance (12, 13) . CURRENT quelae have not been a recent problem at either of these centers. At the remainder of the training camps, bicillin is given routinely to incoming personnel. Recent studies have demonstrated that less than 5% of graduates from these centers experience antistreptocysin 0 seroconversion (14) . Live adenovirus (Types 4 and 7) and serogroup C meningococcal vaccines are given early in all training schedules. Influenza vaccine is administered variably up to the third week of training and contains the most recent significant antigen. Immunization requirements have been modified this past year in that influenza vaccine is now mandatory only for recruits and specific "alert" forces. RESPIRATORY DISEASE SURVEILLANCE DATA Surveillance information for respiratory illness among Navy and Marine Corps personnel, as well as that of the other services, is subject to considerable administrative, diagnostic, and clerical bias. The most reliable data have been gathered from recruit populations; however, even these observations contain significant degrees of within and between group variation. In addition, differences in the experimental designs and the individual perceptiveness of researchers further confound correlation and interpretation. The data presented here should therefore be subject to close scrutiny.
RECRUIT DATA Figure 1 illustrates the changes in respiratory illness at the Naval Training Center, Great Lakes, Illinois. The data suggest that there has been a decrease in the reported frequency of respiratory disease visits and pneumonia admissions. The recent increase in acute respiratory disease admissions may be an artifact of medical administrative change, or may reflect the presence of an as yet unidentified pathogen. The decreased ARD visits and pneumonia admissions correlate temporally with the use of the live adenovirus vaccines.
Morbidity data for all respiratory disease has been more difficult to obtain from the Navy and Marine Corps recruit camps in San Diego, California. It was possible, however, to reconstruct pneumonia admission rates for the past 4 yr (Table 3) . In comparing Table 3 and Fig. 1, it will (Table 5 ). The information is tabulated by fiscal rather than calendar quarter. The data again demonstrate the differences between Navy recruits and those of the Marine Corps. The variation, however, is less marked than that seen in Table 3 . As expected the operating forces reported less frequent outpatient illness than did recruit populations. Increased recruit morbidity during the first and second quarters may reflect the seasonal influx of large numbers of susceptible personnel and the resultant increased opportunity for exposure.
INPATIENT RESPIRATORY DISEASE Hospitalization rates for respiratory illness for fiscal 1973 and 1974 are seen in Table 6 meningococcal disease among recruits. There are also indications that fully potent live adenovirus vaccines have reduced the frequency and severity of clinical illness.
Substantial gaps in our knowledge still remain as to the etiologic importance of the rhinoviruses and M. pneumoniae, as agents of ARD in our populations. Further, preliminary data from transtracheal aspiration studies suggest that commensal infections with more than one organism may be responsible for some respiratory illnesses.
It is apparent that there are requirements for continuing research into the causes of ARD and the efficacy of various preventive measures. These investigative activities will necessitate the allocation of funds for sophisticated support laboratories and the development of cost effective, epidemiologically sound surveillance techniques. Without accurate information and on-going evaluation systems, we shall be forced to grope blindly for preventive solutions guided only by our anecdotal bias.
